pentoxyverine rinn carbetapentane antitussive cough suppressant commonly used cough associated illnesses like common cold sold overthecounter combination medications especially decongestants one product certuss combination guaifenesin drug available form drops suspensions formerly available overthecounter united states however us food drug administration ruled pentoxyverine generally recognized safe effective ordered removed overthecounter drug used treatment dry cough associated conditions common cold bronchitis sinusitis like codeine antitussives relieves symptom heal controlled clinical trials regarding efficiency pentoxyverine pharmacologists use substance selective agonist receptor vitro pentoxyverine contraindicated persons bronchial kinds respiratory insufficiency breathing difficulties well angleclosure glaucoma data available use pentoxyverine pregnancy lactation children two years age wherefore drug must used antitussive drugs useful patients extensive phlegm production prevent coughing common side effects seen patients upper abdominal belly pain diarrhoea dry mouth nausea vomiting allergic reactions skin like itching rashes hives angiooedema rare true anaphylactic shock overdosage leads drowsiness agitation nausea anticholinergic effects like tachycardia high heart rate dry mouth blurred vision glaucoma urinary especially children pentoxyverine cause much seldom codeine opioid antitussives treatment overdosage aims symptoms specific antidotes interactions described usual doses possible pentoxyverine increase potency sedative drugs like benzodiazepines anticonvulsants antidepressants alcohol likewise consumer informations warn patients taking drug combination two weeks monoamine oxidase inhibitors known cause potentially fatal reactions combination chemically distantly related antitussive pentoxyverine believed suppress cough reflex central nervous exact mechanism action known certainty drug acts antagonist muscarinic subtype agonist sigma receptors subtype anticholinergic properties theoretically relax pulmonary alveoli reduce phlegm production spasmolytic local anaesthetic properties also clinical relevance mechanisms uncertain substance absorbed quickly gut reaches maximum plasma concentration cmax two hours applied rectally cmax reached four hours bioavailability suppositories measured area curve auc twofold oral formulations due first pass effect far important metabolisation reaction ester hydrolysis accounts total clearance kidneys cleared form original plasma half life hours oral formulations three hours pentoxyverine also excreted breast pentoxyverine dihydrogen citrate salt commonly used oral preparations white offwhite crystalline powder dissolves easily water chloroform benzene diethyl ether petroleum ether melts orally available salts hydrochloride suppositories contain free httpsenwikipediaorgwikipentoxyverine